BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19150050)

  • 1. [Cutaneous toxicity associated with paclitaxel administration].
    Pérez Rodrigo I; Rubio Pérez MJ; Albornoz López R; Abellón Ruiz J
    Farm Hosp; 2008; 32(5):302-4. PubMed ID: 19150050
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma-like drug reaction to paclitaxel (Taxol).
    Läuchli S; Trüeb RM; Fehr M; Hafner J
    Br J Dermatol; 2002 Sep; 147(3):619-21. PubMed ID: 12207621
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption.
    Young PC; Montemarano AD; Lee N; Sau P; Weiss RB; James WD
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):313-4. PubMed ID: 8642105
    [No Abstract]   [Full Text] [Related]  

  • 4. Nail changes due to docetaxel.
    Pavithran K; Doval DC
    Br J Dermatol; 2002 Apr; 146(4):709-10. PubMed ID: 11966714
    [No Abstract]   [Full Text] [Related]  

  • 5. Generalized pustular dermatosis following paclitaxel therapy.
    Weinberg JM; Egan CL; Tangoren IA; Li LJ; Laughinghouse KA; Guzzo CA
    Int J Dermatol; 1997 Jul; 36(7):559-60. PubMed ID: 9268763
    [No Abstract]   [Full Text] [Related]  

  • 6. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 7. A localised skin reaction after chemotherapy.
    Kahan J; Banner R
    BMJ; 2018 Mar; 360():k469. PubMed ID: 29496750
    [No Abstract]   [Full Text] [Related]  

  • 8. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
    Kupfer I; Balguerie X; Courville P; Chinet P; Joly P
    J Am Acad Dermatol; 2003 Feb; 48(2):279-81. PubMed ID: 12582404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
    Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
    J Dermatol; 2015 Nov; 42(11):1134-5. PubMed ID: 26299585
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous fixed drug eruption to paclitaxel; a case report.
    Baykal C; Erkek E; Tutar E; Yüce K; Ayhan A
    Eur J Gynaecol Oncol; 2000; 21(2):190-1. PubMed ID: 10843484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-induced cutaneous change mimicking malignancy in a previous cutaneous eruption.
    Salas-Martínez AM; Caballero CI; González-Vela MC; Mira MC; Laso-Dosal F; Val-Bernal JF
    Rev Esp Patol; 2018; 51(3):188-192. PubMed ID: 30012313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of clinical experience with paclitaxel extravasations.
    Stanford BL; Hardwicke F
    Support Care Cancer; 2003 May; 11(5):270-7. PubMed ID: 12690542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.
    Yeo W; Leung SF; Johnson PJ
    Eur J Cancer; 1997 Apr; 33(4):698-9. PubMed ID: 9274459
    [No Abstract]   [Full Text] [Related]  

  • 14. Subungual abscess: a new ungual side-effect related to docetaxel therapy.
    Vanhooteghem O; Richert B; Vindevoghel A; Vandenbossche L; Vandeveire A; de la Brassinne M
    Br J Dermatol; 2000 Aug; 143(2):462-4. PubMed ID: 10951175
    [No Abstract]   [Full Text] [Related]  

  • 15. Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
    Payne JY; Holmes F; Cohen PR; Gagel R; Buzdar A; Dhingra K
    South Med J; 1996 May; 89(5):542-5. PubMed ID: 8638189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy.
    Dourakis SP; Sevastianos VA; Alexopoulou A; Deutsch M; Stavrianeas N
    J Clin Oncol; 2002 Jul; 20(13):3030-2. PubMed ID: 12089234
    [No Abstract]   [Full Text] [Related]  

  • 17. Scleroderma and the taxanes. Is there really a link?
    Farrant PB; Mortimer PS; Gore M
    Clin Exp Dermatol; 2004 Jul; 29(4):360-2. PubMed ID: 15245529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yellow nails].
    Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
    Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
    [No Abstract]   [Full Text] [Related]  

  • 19. Use caution when managing paclitaxel and taxotere infiltrations.
    Goodman M; Stewart I; Lydon J; Blendowski C; Barnicle M; Petersen J; Wickham R
    Oncol Nurs Forum; 1996 Apr; 23(3):541-2. PubMed ID: 8801516
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe necrosis due to paclitaxel extravasation.
    Herrington JD; Figueroa JA
    Pharmacotherapy; 1997; 17(1):163-5. PubMed ID: 9017777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.